ERNA · Categories · Form 4
ERNA - SEC Form 4 insider transactions
Ernexa Therapeutics Inc. (ERNA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ERNA
- Sr. VP of Finance Gurrola Sandra M converted options into 30 shares, increasing direct ownership by 38% to 110 units (SEC Form 4)4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Director Wexler William A.4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Sr. VP of Finance Gurrola Sandra M4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Director Bristol James Arthur4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Director Cicala Peter4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by President & CEO Luther Sanjeev4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Director Ratner Elena4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- Sr. VP of Finance Gurrola Sandra M converted options into 437 shares and covered exercise/tax liability with 180 shares, increasing direct ownership by 28% to 1,185 units (SEC Form 4)4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Cicala Peter4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Bristol James Arthur4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Gurrola Sandra M4 - Eterna Therapeutics Inc. (0000748592) (Issuer)